In the medical field, blood type has always been a key issue, and the ABO blood group system plays an irreplaceable role. This system marks the presence of A and B antigens on red blood cells, affecting the safety of blood transfusions and organ transplants. When blood type mismatch occurs, it can lead to fatal reactions, which makes the importance of ABO blood type even more prominent. This article takes an in-depth look at how Karl Landsteiner's discoveries changed our understanding of human blood.
In 1901, Austrian physician Karl Landsteiner discovered the ABO blood group system. This achievement earned him the Nobel Prize in Physiology or Medicine in 1930. Landsteiner began conducting blood experiments while working at the Institute of Pathological Anatomy in Vienna. He discovered that red blood cells agglutinated when different human bloods were mixed. This was the first time he became aware of the variability of human blood.
"Healthy human serum can not only agglutinate animal red blood cells, but can often agglutinate other human blood as well."
Put simply, this is the first evidence of blood differences, as it was previously thought that all people's blood was similar. In 1901, Landsteiner conducted more in-depth research on blood and divided human blood into three categories: type A, type B and type C. He pointed out that type A blood is only compatible with type A blood, while type B blood is compatible with type B blood. This discovery eventually led to the classification of ABO blood groups.
The ABO blood type is controlled by a single gene, which encodes three alleles: i, IA and IB. Different combinations of these genes determine an individual's blood type. Specifically, the IA allele corresponds to type A blood, IB corresponds to type B, and i is the gene for type O blood. These genes are located on chromosome nine and govern the types of antigens in our blood.
"The inheritance of blood types can determine what kind of children parents are likely to give birth to. This phenomenon is particularly significant in ABO blood types."
Since Landsteiner, scientists around the world have conducted further research into blood group classification systems. Czech serologist Jan Janski independently published a blood group classification in 1907, using the Roman numerals I to IV to represent the modern blood types O, A, B and AB respectively. The introduction of this classification system caused confusion in the medical community because American physician William L. Moss proposed a slightly different classification method.
It was not until 1921 that major academic organizations decided to officially use Landsteiner's letters to name the ABO blood group system after discussions. This decision gradually became generally accepted in the following decades.
ABO blood type not only plays a vital role in blood transfusions, but is also involved in the risk of multiple diseases. For example, studies indicate that individuals with type O blood are at higher risk for bleeding because they generally have lower levels of von Willebrand factor in their plasma. In addition, blood type affects susceptibility to certain cancers and the composition of the body's microbiome.
"In some cancers, the expression of ABO blood group antigens can serve as an important clinical indicator of cancer progression."
With the development of genomics and molecular biology, our understanding of ABO blood types is also constantly deepening. For example, studies have shown that ABO blood group genes are associated with susceptibility to pancreatic cancer, demonstrating the potential of ABO blood groups in oncology. In addition, the scientific community is also exploring how to improve the safety of blood transfusions by changing the ABO antigens in the blood.
The discovery of the ABO blood type had a profound impact on modern medicine. Landsteiner's research not only revealed the diversity of blood, but also promoted the establishment of global blood safety standards. Although we may consider this knowledge relatively mature today, in the face of rapid changes in biomedicine, we cannot help but ask, will future research be able to unlock more secrets about our blood?